EyePoint, Inc. Debt Instrument, Fee Amount
EyePoint, Inc. (EYPT) had Debt Instrument, Fee Amount of $2.10 million as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentFeeAmount · last filed 2019-05-10
- 2019-03-31: Debt Instrument, Fee Amount $2.10M.
- 2018-12-31: Debt Instrument, Fee Amount $0.00.
- 2018-06-30: Debt Instrument, Fee Amount $1.20M.
- 2018-03-31: Debt Instrument, Fee Amount $900.00K.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2019-03-31 | $2.10M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.00 10-KT · filed 2019-03-18 |
| 2018-06-30 | $1.20M 10-KT · filed 2019-03-18 |
| 2018-03-31 | $900.00K 10-Q · filed 2019-05-10 |
| 2017-06-30 | $0.00 10-KT · filed 2019-03-18 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2016-06-30 | $0.00 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |